Tag: Tandem Diabetes Care
In brief: Not guilty verdict, Tandem Diabetes recall, Healthcare Growth Group launch
August 23, 2024HME News Staff
SAN ANTONIO – Kuba Zarobkiewicz and Anthony Fermin, owners of DME companies, have been found not guilty of health care fraud, violations of the Anti-Kickback Statute and conspiracy charges by a federal jury.
Zarobkiewicz and Fermin ran brace businesses through multiple companies beginning in 2020 and then voluntarily shut them down in late 2021. They began cooperating with a law enforcement investigation in September 2022 and then were charged in December 2022 in the Western District...
Tandem offers update on recall
August 21, 2024HME News Staff
SAN DIEGO – Tandem Diabetes Care on Aug. 9 emailed notices to customers impacted by a recall of its Apple OS t:connect mobile app. The recall, issued in March, relates to an issue that can cause rapid depletion of a user’s t:slim X2 insulin pump battery, causing the insulin pump to shut down sooner than expected. Tandem plans to release a new version of the app to address the remaining issues and will notify all users by email and app push notifications following its release. Tandem strongly...
Tandem, Dexcom integration approved in Canada
August 1, 2024HME News Staff
MARKHAM, Ontario – Tandem Diabetes Care and Dexcom have announced the updated t:slim X2 insulin pump software is compatible with both Dexcom G7 and Dexcom G6 Continuous Glucose Monitoring (CGM) Systems and is authorized for sale by Health Canada. This integration allows users of the t:slim X2 insulin pump with Control-IQ technology, to have even more choice in how they manage their diabetes. "This integration marks the first time an AID system in Canada is compatible with both Dexcom G7...
Tandem backs up efficacy of Mobi
June 25, 2024HME News Staff
SAN DIEGO – Eighty-six percent of participants were satisfied or very satisfied with Tandem Diabetes Care’s Mobi regardless of prior therapy and agreed the automated insulin delivery system improves their quality of life, according to survey results the company presented at the 84th Scientific Sessions of the American Diabetes Association. “These real-world user insights provide evidence that we are furthering our mission to improve the lives of people with diabetes by demonstrating...
Product launches: ResMed, Tandem Diabetes Care
February 13, 2024HME News Staff
ResMed has launched its AirCurve 11 series of bilevel devices. The AirCurve 11 uses two levels of support – inspiratory positive airway pressure (IPAP) and expiratory positive airway pressure (EPAP) –and is also built on the company’s AirSense 11 platform. Other features include integrated heated humidifier, engagement tools like AirView, myAir and Personal Therapy Assistant. “Patient care is our top priority, and that includes their comfort and compliance with PAP therapy,”...
Abbott, Tandem integrate
January 9, 2024HME News Staff
ABBOTT PARK, Ill., and SAN DIEGO – Abbott and Tandem Diabetes Care have announced that the t:slim X2 insulin pump with Control-IQ technology is the first automated insulin delivery system to integrate with the newly available FreeStyle Libre 2 Plus sensor. For the first time, FreeStyle Libre technology users in the United States are now able to experience the therapeutic benefits of a hybrid closed-loop system that helps predict and prevent high and low blood sugar. “Tandem’s leadership...
Tandem launches diabetes management platform
December 20, 2023HME News Staff
SAN DIEGO – Tandem Diabetes Care has launched Tandem Source, a diabetes management platform for insulin pump users and health care providers. Tandem Source brings together the features of Tandem’s legacy t:connect, t:connect HCP, and t:connect Portal offerings with new comprehensive data reporting in one central, scalable platform. “The launch of Tandem Source offers new, easy-to-use reports and the consolidation of several platforms and features into a single, convenient location...
In brief: Inogen buy, UPitt grant, telehealth decrease
July 14, 2023HME News Staff
GOLETA, Calif. - Inogen has entered into a definitive agreement to acquire Physio-Assist SAS, a privately held company based in France that makes a technology-enabled airway clearance device called Simeox, for $32 million.
Simeox has been cleared under CE mark in the EU and is currently being sold in Europe, Asia and the Middle East.
“This acquisition aligns with our strategy to diversify our portfolio to globally improve patient lives through respiratory care,” said...
Tandem Mobi gets FDA approval
July 13, 2023HME News Staff
SAN DIEGO – Tandem Diabetes Care has received U.S. Food and Drug Administration clearance for the Tandem Mobi insulin pump for people with diabetes age 6 and up. The Tandem Mobi is fully controllable from a mobile app. “Testing the limits of pump miniaturization, Tandem Mobi joins the t:slim X2 pump in our family of insulin delivery solutions bringing new options in wearability, the flexibility to disconnect, and full phone control,” said John Sheridan, president and CEO. “Through...
Tandem study shows great improvement for high A1c
April 18, 2023HME News Staff
SAN DIEGO – Tandem Diabetes Care, has published the result of a meta-analysis of three randomized controlled trials of its Control-IQ advanced hybrid closed-loop technology. The results, published in Diabetes Technology & Therapeutics demonstrate the positive clinical impact of the system’s automatic correction bolusing on glucose control across a wide range of ages and demographics of people with Type 1 diabetes. People with the highest baseline blood sugar levels experienced the greatest...